Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Regimen for Severe Hemophilia
NCT05920512Phase 2Recruiting
- Start
- Apr 2022
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid, sirolimus, calcitriol in hemophilia A, hemophilia B (HB). Started Apr 2022; status: recruiting.
02
Drugs
valproic acidsirolimuscalcitriol
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT05920512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05920512.